Skip to content
Catalyst

OutcomesOutcome

Faecal Bifidobacterium count

1 finding from 1 compound ↓reported in log10 cells/g faeces (or CFU/g)

Faecal Bifidobacterium count

1 finding · 1 compound · by evidence strength. No dose is advised.

Fig. 2 Faecal Bifidobacterium count1 compound outer ring on requestSelected Faecal Bifidobacterium count · centre
×1.60
Labels
Measured outcomeInspector

Faecal Bifidobacterium count

Findings drawn, by strength

1finding · 1 compound

  • Very limited1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound raisesFindingsStrongest
1
Very limited

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Reported to move it1 finding

  1. Bifidobacterium longumMoved: raisesEvidence: Very limitedPaper: PMID 235996422013
    Who
    Elderly long-term inpatients receiving enteral tube feeding (age 65-102); faecal samples collected in the second trial only
    Dose studied
    BB536-L approximately 2.5 × 10¹⁰ cfu or BB536-H approximately 5 × 10¹⁰ cfu, 16 weeks, via enteral feeding

    BB536 intake also significantly (P < 0.01) increased the cell numbers of bifidobacteria in fecal microbiota, and significant intergroup differences were observed at week 16.”

    Quoted verbatim from Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.RCT · 4 monthsPermalink

How it is measured

Bifidobacteria in stool by plate count, FISH or quantitative PCR, in log10 cells or colony-forming units per gram of faeces, or as a percentage of total bacteria. The method and whether the value is a count or a relative abundance are recorded with each finding.

Papers about it

As an endpoint1

Show the paperHide the paper
  • Modulatory effects of Bifidobacterium longum BB536 on defecation in elderly patients receiving enteral feeding.

    World journal of gastroenterology2013PMID 23599642Via: named in the paper, as read